Simultaneous Optical Imaging of Action Potentials and Calcium Transients in Human Induced Pluripotent Stem

Hao Yang1, Yuan Yang1, Zijun Lu1

  • 1Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, China.

Current Protocols
|July 9, 2024
PubMed

Insights

This study presents a new high-throughput method using optical imaging to simultaneously measure action potentials and calcium transients in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for cardiovascular drug discovery.

Area of Science:

  • Cardiology
  • Stem Cell Biology
  • Pharmacology

Background:

  • Cardiovascular diseases are a leading cause of mortality.
  • Drug discovery for cardiovascular diseases is limited by the lack of suitable in vitro platforms.
  • Human induced pluripotent stem cells (hiPSCs) differentiated into cardiomyocytes (hiPSC-CMs) offer a promising model, but require functional monitoring.

Purpose of the Study:

  • To develop and present a comprehensive protocol for the simultaneous optical measurement of action potentials (APs) and intracellular calcium (Ca2+) transients in hiPSC-CMs.
  • To establish a high-throughput platform for cardiovascular disease modeling and drug screening.
  • To facilitate the discovery of novel compounds targeting cardiovascular diseases characterized by abnormal APs and Ca2+ handling.

Main Methods:

  • Adaptation of the IonOptix system for simultaneous optical detection.
  • Loading hiPSC-CMs with fluorescent dyes FluoVolt (for APs) and Rhod 2 (for Ca2+ transients).
  • Detailed protocols for hiPSC-CM preparation, device setup, optical imaging, and data analysis.

Main Results:

  • Successful simultaneous measurement of APs and Ca2+ transients in hiPSC-CMs.
  • Demonstration of a powerful high-throughput platform for functional assessment of hiPSC-CMs.
  • Establishment of a comprehensive protocol for researchers.

Conclusions:

  • The developed optical imaging system provides a robust platform for monitoring hiPSC-CM function.
  • This method aids in the discovery of new drugs for cardiovascular diseases by analyzing cellular phenotypes.
  • The protocol enables efficient and simultaneous assessment of critical cardiomyocyte parameters.

Related Concept Videos